Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,980 | 398 | 99.9% |
| Education | $4.64 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,010 | 70 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $643.55 | 39 | $0 (2024) |
| Lilly USA, LLC | $571.55 | 45 | $0 (2024) |
| GlaxoSmithKline, LLC. | $549.26 | 39 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $504.46 | 43 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $377.93 | 23 | $0 (2024) |
| PFIZER INC. | $368.42 | 19 | $0 (2024) |
| Abbott Laboratories | $301.92 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $291.03 | 18 | $0 (2020) |
| Amgen Inc. | $244.17 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $673.60 | 36 | Novo Nordisk Inc ($130.37) |
| 2023 | $607.16 | 38 | Lilly USA, LLC ($132.89) |
| 2022 | $778.43 | 46 | Lilly USA, LLC ($132.71) |
| 2021 | $130.96 | 7 | Boehringer Ingelheim Pharmaceuticals, Inc. ($99.91) |
| 2020 | $209.13 | 14 | Boehringer Ingelheim Pharmaceuticals, Inc. ($52.88) |
| 2019 | $968.64 | 70 | Novo Nordisk Inc ($223.49) |
| 2018 | $1,090 | 80 | Novo Nordisk Inc ($215.83) |
| 2017 | $1,526 | 108 | Novo Nordisk Inc ($238.54) |
All Payment Transactions
399 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.71 | General |
| 11/20/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: VACCINES | ||||||
| 11/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Diabetes Care | ||||||
| 11/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Bone Health | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Diabetes Care | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Respiratory | ||||||
| 09/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Oncology | ||||||
| 08/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Diabetes Care | ||||||
| 07/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.09 | General |
| 06/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: RESPIRATORY | ||||||
| 06/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Obesity | ||||||
| 05/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Diabetes | ||||||
| 05/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Obesity | ||||||
| 05/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: RESPIRATORY | ||||||
| 05/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Respiratory | ||||||
| 04/29/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Diabetes | ||||||
| 04/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Diabetes Care | ||||||
| 04/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Diabetes | ||||||
| 04/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Respiratory | ||||||
| 04/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,071 | 1,406 | $251,590 | $63,574 |
| 2022 | 12 | 1,111 | 1,448 | $244,555 | $63,580 |
| 2021 | 12 | 1,046 | 1,361 | $222,268 | $63,032 |
| 2020 | 14 | 1,079 | 1,556 | $220,410 | $61,121 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 111 | 182 | $77,350 | $14,015 | 18.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 143 | 241 | $72,300 | $13,534 | 18.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 112 | 112 | $22,400 | $13,149 | 58.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 118 | 119 | $23,950 | $6,363 | 26.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $8,750 | $3,951 | 45.2% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2023 | 141 | 301 | $19,565 | $3,213 | 16.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 30 | 30 | $6,000 | $2,158 | 36.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 121 | 121 | $3,025 | $2,022 | 66.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 116 | 116 | $2,900 | $1,938 | 66.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 47 | 47 | $1,410 | $1,382 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 75 | 79 | $7,505 | $657.09 | 8.8% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 16 | 16 | $3,200 | $535.84 | 16.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $435.00 | $411.71 | 94.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 14 | $2,800 | $245.28 | 8.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 120 | 120 | $24,000 | $14,898 | 62.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 148 | 256 | $76,100 | $14,598 | 19.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 106 | 166 | $69,200 | $12,375 | 17.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 124 | 124 | $24,800 | $7,094 | 28.6% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2022 | 146 | 313 | $20,345 | $3,501 | 17.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 51 | 51 | $10,200 | $3,496 | 34.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 125 | 125 | $3,125 | $2,220 | 71.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 124 | 124 | $3,100 | $2,162 | 69.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 55 | 55 | $1,650 | $1,561 | 94.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 18 | 19 | $3,725 | $695.00 | 18.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 83 | 84 | $7,980 | $664.19 | 8.3% |
About Dr. Jun Lee, MD
Dr. Jun Lee, MD is a Internal Medicine healthcare provider based in Frisco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1891795522.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jun Lee, MD has received a total of $5,984 in payments from pharmaceutical and medical device companies, with $673.60 received in 2024. These payments were reported across 399 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,980).
As a Medicare-enrolled provider, Lee has provided services to 4,307 Medicare beneficiaries, totaling 5,771 services with total Medicare billing of $251,307. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Frisco, TX
- Active Since 07/22/2005
- Last Updated 03/17/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1891795522
Products in Payments
- JARDIANCE (Drug) $652.00
- JANUVIA (Drug) $305.89
- Ozempic (Drug) $262.99
- Victoza (Drug) $249.51
- XARELTO (Drug) $201.75
- FARXIGA (Drug) $200.56
- Prolia (Biological) $184.03
- MOUNJARO (Drug) $175.35
- FREESTYLE LIBRE 3 (Device) $152.64
- SHINGRIX (Biological) $151.27
- ANORO (Drug) $149.57
- NURTEC ODT (Drug) $135.10
- Tresiba (Drug) $131.73
- TRULICITY (Drug) $129.40
- Xhance (Drug) $116.19
- EMGALITY (Drug) $112.14
- Rybelsus (Drug) $112.11
- Creon (Drug) $96.11
- ELIQUIS (Drug) $95.22
- TRADJENTA (Drug) $90.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Frisco
Jasbir Dhawan, Md, MD
Internal Medicine — Payments: $320,303
Jason Riehs, Md, MD
Internal Medicine — Payments: $201,897
Dr. Naveen Sikka, M.d, M.D
Internal Medicine — Payments: $96,322
Dr. Sibi Thomas, D.o, D.O
Internal Medicine — Payments: $75,591
Stephanie Berg, Md, MD
Internal Medicine — Payments: $42,134
Ramesh Amara, Md, MD
Internal Medicine — Payments: $13,128